Actinium Pharmaceuticals's total assets for Q were $89.86M, an increase of 1.71% from the previous quarter. DE:7AY1 total liabilities were $46.03M for the fiscal quarter, a 3.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.